This HIV Research Department grant supports studies evaluating HIV drug resistance and its relationship to treatment success. The funding targets applications exploring genotype/phenotype correlations across diverse HIV subtypes. It also encourages research into the link between minority variants and patient outcomes, alongside investigations into reasons for discordance between genotypic resistance and actual treatment success or failure. Laboratory evaluations of samples with clinical correlates from patients on recommended regimens are highly encouraged, aiming to provide comprehensive insights into this critical area of HIV research.
Opportunity ID: 293906
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-291 |
| Funding Opportunity Title: | HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 17, 2017 |
| Last Updated Date: | Jun 27, 2017 |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2018 |
| Archive Date: | Jun 06, 2018 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education State governments County governments City or township governments Native American tribal governments (Federally recognized) Independent school districts Private institutions of higher education Small businesses For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between minority variants and treatment outcomes and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-291.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated Expiration Date in accordance with the notice NOT-AI-17-031 | Jun 27, 2017 | |
| Jun 27, 2017 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-291 |
| Funding Opportunity Title: | HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | May 17, 2017 |
| Last Updated Date: | Jun 27, 2017 |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2018 |
| Archive Date: | Jun 06, 2018 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education State governments County governments City or township governments Native American tribal governments (Federally recognized) Independent school districts Private institutions of higher education Small businesses For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between minority variants and treatment outcomes and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-291.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-17-291 |
| Funding Opportunity Title: | HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 27, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities For profit organizations other than small businesses Independent school districts County governments Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to support studies that will evaluate HIV drug resistance and its relationship to treatment success. Applications are sought proposing studies of genotype/phenotype correlations in diverse subtypes, the relationship between minority variants and treatment outcomes and on the reasons for the discordance between genotype and treatment success or failure. Laboratory evaluations of samples with clinical correlates in patients on recommended regimens are encouraged. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-17-291.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00235992 | Nov 09, 2017 | May 07, 2018 | View | |
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00232601 | Aug 07, 2017 | Jan 24, 2018 | View |
Package 1
Mandatory forms
293906 RR_SF424_2_0-2.0.pdf
293906 PHS398_CoverPageSupplement_4_0-4.0.pdf
293906 RR_OtherProjectInfo_1_4-1.4.pdf
293906 PerformanceSite_2_0-2.0.pdf
293906 RR_KeyPersonExpanded_2_0-2.0.pdf
293906 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
293906 RR_Budget_1_4-1.4.pdf
293906 RR_SubawardBudget30_1_4-1.4.pdf
293906 PHS398_ModularBudget_1_2-1.2.pdf
293906 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
293906 RR_SF424_2_0-2.0.pdf
293906 PHS398_CoverPageSupplement_3_0-3.0.pdf
293906 RR_OtherProjectInfo_1_3-1.3.pdf
293906 PerformanceSite_2_0-2.0.pdf
293906 RR_KeyPersonExpanded_2_0-2.0.pdf
293906 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
293906 RR_Budget_1_3-1.3.pdf
293906 RR_SubawardBudget30_1_3-1.3.pdf
293906 PHS398_ModularBudget_1_2-1.2.pdf
293906 PHS_Inclusion_Enrollment_Report-1.0.pdf
293906 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
